Drug Pipeline

Epoetin Alfa Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
4
Recruiting
3
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 3
3
Phase 2
2
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07422480 A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low… Myelodysplastic Syndrome Recruiting
NCT05949684 ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants… Myelodysplastic Syndromes Active, Not Recruiting
NCT00843882 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic… Anemia Active, Not Recruiting
Phase 2
NCT05564390 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study… Acute Myeloid Leukemia Recruiting
NCT07463820 A Trial Comparing Three Different Treatment Options for Adults With Low-Risk… Myelodysplastic Syndrome Not Yet Recruiting
Phase 1/2
NCT05181735 Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being… MDS Recruiting
Phase 1
NCT06832189 EVR and EPO for Liver Transplant Tolerance Liver Transplant Recruiting
Sponsors Running Epoetin Alfa Trials
Disease Areas
Get alerts when Epoetin Alfa trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free